Explore the implications of GLP-1 drugs in managing India's obesity crisis as experts warn of potential misuse and health ...

U.S. Non-Invasive Fat Reduction Market Expected to Surpass USD 2.07 Billion by 2032 at a CAGR of 16.45%, Fueled by Disposable Income and Demand for S ...